evipedia.ai
← Back

Celery Seed Extract for Health & Longevity

Evidence Review created on 08/25/2026 using AI4L / Opus 5

Also known as: Apium graveolens Seed Extract, Celery Fruit Extract, Celery Seed Oil Extract, Celery Seed Oleoresin, 3nB Extract

Motivation

Celery seed extract is a concentrated preparation made from the small aromatic fruits of the celery plant rather than from its familiar stalks. The seed carries most of the plant’s pharmacologically interesting chemistry, and a single capsule delivers far more of it than anyone could obtain by eating the vegetable. Commercial products are standardized to a fat-soluble aroma compound that is found in almost no other food.

Celery seed has a long record in Ayurvedic, Persian, and European herbal practice as a remedy for joint pain, swelling, and urinary complaints. In China, a single purified compound isolated from celery seed oil was developed into an approved medicine for stroke, giving the plant an unusual dual identity as both kitchen spice and pharmaceutical starting material. Small controlled trials in people with high blood pressure later renewed commercial interest in the whole extract.

This review examines what the human and animal evidence shows about celery seed extract for blood pressure, blood fats, and uric acid; the allergy and safety questions it raises; how it is dosed, sourced, and monitored; and how much confidence the underlying research supports.

Benefits - Risks - Protocol - Conclusion

This section lists high-level, non-systematic sources that discuss celery seed extract by name in substantial depth.

Only four sources qualified rather than five. Celery seed extract is a small commercial niche, and the eligible non-systematic literature that discusses it by name in depth is correspondingly thin; the list was not padded with marginally relevant apigenin or celery-juice content. Of the priority experts, only Life Extension Magazine has published substantial material on this specific extract — Rhonda Patrick, Peter Attia, Andrew Huberman, Chris Kresser, and Lifespan.io have not covered it.

Grokipedia

  • Celery

    Covers the plant’s botany, the seed’s role as a spice, its traditional diuretic and anti-inflammatory uses, and its allergy potential, supplying botanical and culinary background the clinical literature omits.

Examine

  • Celery Seed Extract

    Grades the evidence for blood pressure and tallies the trial base behind it, giving a commercially unaffiliated read on how strong the cardiovascular claim actually is.

ConsumerLab

ConsumerLab has published no product review and no dedicated article on celery seed extract. The supplement has never been included in its independent purity and potency testing programme, so no third-party label-accuracy data for this category exists from that source.

Systematic Reviews

The systematic reviews and meta-analyses below cover the cardiometabolic claim, the reproductive signal, and the allergy question.

No systematic review or meta-analysis addresses adverse events of concentrated celery seed extract supplements as such. The principal risk of this intervention — allergic reaction — is therefore represented only indirectly, through the pollen-related food allergy review above; the risk side of the trade-off is otherwise unrepresented in the systematic-review literature.

Mechanism of Action

Celery seed extract acts through several constituent families rather than one active molecule. The best-characterized is 3-n-butylphthalide (3nB, the oily compound that gives celery its smell), which relaxes arteries. In isolated rat aorta, celery seed extract produced concentration-dependent relaxation that at low concentrations partly required an intact endothelium (the vessel’s inner lining) but worked mainly by blocking calcium entry into vascular smooth muscle and opening voltage-dependent potassium channels; blocking two other vessel-relaxing signals, nitric oxide and prostaglandins, did not abolish it. This works much as calcium channel blocker drugs do. A narrative review of the antihypertensive literature adds diuretic and heart-rate-slowing actions.

A second family is the flavonoids apigenin, luteolin, and chrysoeriol. These inhibit xanthine oxidase, the enzyme that manufactures uric acid, with chrysoeriol and luteolin the most potent; this is the same target as the gout drug allopurinol, though celery’s constituents are far weaker. The same flavonoids are antioxidant and dampen inflammatory signalling.

Competing mechanistic accounts exist. Advocates of the calcium-channel model note the direct vascular data; sceptics point out that plasma 3nB from a supplement dose is orders of magnitude below the concentrations used in vessel-bath experiments, and argue the diuretic and mild sympathetic effects, not channel blockade, explain the clinical readings. Human pharmacology shows 3nB is extensively oxidized by CYP3A4, CYP2E1, and CYP1A2 (liver enzymes that break down most drugs) with about 82 percent of a dose recovered in urine as metabolites, implying a short residence time of a few hours and heavy first-pass loss.

Historical Context & Evolution

Celery was cultivated around the Mediterranean as a medicinal and ritual plant long before it became a salad vegetable, and the seed — botanically a small dried fruit — was the medicinal part. Ayurvedic practice used it as ajmoda for digestive complaints and joint pain; Greek, Roman, and later European herbals prescribed it as a diuretic and for what would now be called gout and rheumatism. Persian medicine used seed preparations for dyspepsia (indigestion) and for what texts described as female sexual weakness. These original uses were symptomatic and traditional, not hypothesis-driven.

Two twentieth-century developments moved it toward health optimization. First, Chinese pharmacologists isolated 3-n-butylphthalide from celery seed oil, and the racemic synthetic version was developed and approved in China as a treatment for acute ischaemic stroke — an unusual case of a culinary plant yielding a registered drug. Second, from the 1990s an Australian and Indian collaboration produced a standardized alcoholic seed extract and reported anti-inflammatory, pain-relieving, stomach-protecting, and antibacterial activity without clear toxicity.

Scientific opinion has not settled. Early enthusiasm rested on animal work and one small pilot trial; the pilot was criticized as underpowered and industry-linked, and its findings were sometimes dismissed as unreplicated. That dismissal has itself weakened: independent randomized trials in Iran and Mexico have since reported blood pressure and uric acid effects, while a 2025 meta-analysis found significant pooled effects alongside substantial heterogeneity. What changed is the quantity of controlled data, not the size or duration of the trials.

Expected Benefits

High 🟩 🟩 🟩

Blood Pressure Reduction in Treated Hypertension

Celery seed extract lowers blood pressure through vascular calcium-channel blockade and mild diuresis. A meta-analysis of ten randomized controlled trials (RCTs, studies in which participants are randomly assigned to treatment or placebo) in 511 adults found significant reductions in both readings, with seed preparations above 1,000 mg daily performing best. A triple-blind, placebo-controlled crossover trial in 52 hypertensive patients confirmed this on 24-hour ambulatory monitoring. Trials are small, short, heterogeneous, and several come from one Iranian group.

Magnitude: In the crossover trial, systolic (upper) pressure fell from 141.2 to 130.0 mmHg and diastolic (lower) from 92.2 to 84.2 mmHg over four weeks at 1.34 g/day (both p < 0.001); the pooled standardized mean difference (SMD, an effect size that allows different scales to be combined) was −1.00 for systolic pressure (95% confidence interval, or CI, the plausible range for the true effect: −1.85 to −0.14).

Medium 🟩 🟩

Blood Lipid Improvement ⚠️ Conflicted

The evidence splits by outcome. Pooled analysis showed a large, consistent triglyceride reduction but no effect on total, low-density lipoprotein (LDL, the cholesterol fraction that drives artery plaque), or high-density lipoprotein (HDL, the fraction that helps clear it) cholesterol. Individual trials disagree: a four-week crossover trial reported lower total and LDL cholesterol with higher HDL, while a 12-week trial at a much lower dose moved only triglycerides. The most likely explanation is dose — 1.34 g/day versus 150 mg/day — plus small samples inflating single-trial estimates.

Magnitude: Pooled triglyceride SMD −1.18 (95% CI −1.45 to −0.91). In the 1.34 g/day crossover trial total cholesterol fell 16.37 mg/dL, triglycerides 16.22 mg/dL, and LDL 11.84 mg/dL, while HDL rose 2.52 mg/dL; the pooled analysis found no cholesterol effect at all.

Fasting Blood Glucose Reduction

Celery preparations modestly lower fasting glucose, plausibly through the antioxidant and anti-inflammatory flavonoid fraction rather than any insulin-secretory action. The meta-analysis found a significant pooled reduction, and the 1.34 g/day crossover trial reproduced it. Importantly, the only trial to measure insulin sensitivity and secretion directly found no significant change — so the glucose effect is real but its mechanism is unexplained, and a separate celery-powder trial in type 2 diabetes found nothing.

Magnitude: Fasting glucose fell from 108.53 to 97.96 mg/dL over four weeks at 1.34 g/day (p < 0.01); pooled SMD −0.80 (95% CI −1.58 to −0.01), an effect whose upper bound sits just short of no effect.

Low 🟩

Serum Uric Acid Lowering

Celery seed flavonoids inhibit xanthine oxidase, the uric-acid-producing enzyme. A randomized placebo-controlled trial in 28 adults with metabolic syndrome found a significant fall at 150 mg/day; affinity screening identified luteolin and apigenin as the binders. That screening came from a manufacturer’s institute.

Magnitude: Serum uric acid fell from 297.4 to 261.7 µmol/L (roughly 5.0 to 4.4 mg/dL) over 12 weeks in 14 treated participants (p = 0.009).

Anxiety and Depressive Symptom Reduction

A crossover trial in 50 hypertensive patients found significant improvements on standard self-report questionnaires, with restlessness, sleep, and fatigue among the items that improved. Because blood pressure fell simultaneously, symptom relief may be secondary rather than a direct mood effect, and self-report scales are the weakest available endpoint.

Magnitude: Beck Anxiety Inventory score fell 6.78 points (p < 0.001) and Beck Depression Inventory score 3.63 points (p < 0.01) over four weeks at 1.34 g/day.

Female Sexual Function

A double-blind randomized trial in 80 women using 500 mg of celery seed three times daily for six weeks reported significantly greater improvement than placebo in overall sexual function, driven by desire, arousal, and lubrication. It is a single unreplicated trial with a subjective endpoint.

Magnitude: Total Female Sexual Function Index score improved significantly more than placebo (p < 0.001) at 1,500 mg/day for six weeks; the report gives no between-group point difference, so no effect size figure is available.

Joint Pain and Cartilage Marker Improvement

A 90-day randomized placebo-controlled trial in 62 people with knee osteoarthritis combining 250 mg celery seed extract with Boswellia serrata resin reported less pain and stiffness plus lower cartilage-breakdown markers. The celery contribution cannot be separated, and the product’s maker funded the trial.

Magnitude: Pain, stiffness, and cartilage-degradation markers all improved over 90 days, but only in combination with Boswellia serrata; no trial reports an outcome figure for celery seed extract alone in osteoarthritis.

Speculative 🟨

Cerebrovascular and Cognitive Protection

The synthetic form of 3nB is an approved stroke drug in China, with animal evidence of brain protection. No trial has tested celery seed extract on any brain endpoint; the basis is mechanistic only.

Gastroprotection and Helicobacter pylori Suppression

Preclinical work reports that a standardized seed extract protects rodent stomachs against painkiller damage and that one fraction inhibits the ulcer bacterium Helicobacter pylori. Only laboratory data from the extract’s developers exist.

Benefit-Modifying Factors

  • Baseline blood pressure: Effects appear confined to people whose pressure is already elevated. Animal work showed reductions only in hypertensive animals, and every positive human trial recruited hypertensive or metabolic-syndrome participants; little change is expected at normal blood pressure.

  • Dose threshold: The meta-analysis found preparations above 1,000 mg/day and seed-derived material outperformed lower doses and other plant parts. Lipid and cholesterol benefits in particular appear only at the higher end.

  • Baseline uric acid and triglycerides: The largest triglyceride and urate reductions occurred in participants who started with metabolic syndrome. Someone already at optimal levels has little headroom, so measured baselines predict who benefits.

  • Genetic variation in drug-metabolizing enzymes: 3nB is cleared by CYP3A4, CYP2E1, and CYP1A2 (liver enzymes that inactivate most drugs). Fast-metabolizer variants of these enzymes plausibly reduce exposure, though no pharmacogenetic study of celery seed extract has been done.

  • Sex: All fertility and testosterone findings come from male animals, while the sexual-function trial enrolled only women. No trial has compared blood pressure or lipid responses between men and women, so sex-specific efficacy is untested.

  • Pre-existing conditions: Concurrent hypertension, metabolic syndrome, or type 2 diabetes defined every positive trial population; conversely a celery-powder trial in overweight adults with type 2 diabetes found no cardiometabolic benefit, so disease context alone does not guarantee response.

  • Age: Trial participants were middle-aged, typically 40 to 65. Adults over 70 are unstudied, and because they are more prone to postural blood pressure drops, the same effect size carries different consequences for them.

Potential Risks & Side Effects

High 🟥 🟥 🟥

Allergic Reactions and Anaphylaxis

Celery is one of fourteen allergens that must be declared on food labels in the European Union. Anaphylaxis (a rapid, whole-body allergic reaction that can obstruct breathing) is the concern: in a study of 79 celery-allergic adults, 49 had systemic rather than merely oral reactions. Sensitization to Api g 7, a celery protein cross-reacting with mugwort pollen, sharply raised the odds of severe reaction. Seed preparations are more potent triggers than cooked root, and registry data rank celery among the most frequent adult food triggers in German-speaking countries.

Magnitude: 62 percent (49 of 79) of celery-allergic adults in the cohort had systemic reactions; Api g 7 sensitization raised the odds of severe anaphylaxis rather than mild oral symptoms roughly six-fold (odds ratio 5.87, 95% CI 1.08 to 32.0).

Medium 🟥 🟥

Additive Blood Pressure Lowering and Hypotension

The benefit and this risk are the same effect. In the crossover trial, the extract was added on top of participants’ existing antihypertensive drugs and still produced a substantial fall, meaning stacked reductions are achievable. For someone already well controlled on medication, the same 8 to 11 mmHg can produce light-headedness, postural dizziness, or falls rather than benefit. Effects appear within weeks, are dose-related, and reverse on discontinuation.

Magnitude: Mean arterial pressure fell 9.0 mmHg (108.5 to 99.5 mmHg) and pulse pressure 3.2 mmHg over four weeks in patients already taking antihypertensive medication.

Low 🟥

Sunlight-Triggered Skin Rash (Phytophotodermatitis) ⚠️ Conflicted

Celery contains furocoumarins, plant chemicals that make skin burn in sunlight. Handling it commonly causes blistering rashes in food workers. Oral intake is contested: a volunteer feeding study found no circulating furocoumarins, yet case reports describe severe burns when celery intake coincided with light therapy or tanning beds.

Magnitude: Risk concentrates in people combining celery intake with intense ultraviolet exposure or handling infected plants; the volunteer feeding study detected no circulating psoralens at any timepoint, and the literature reports no incidence figure for extract capsules.

Reduced Male Fertility with Chronic High-Dose Use

A systematic review of sixteen studies found most reported protective effects on sperm, but three reported inhibition. The reviewers attributed the inhibitory signal to apigenin at high concentration or with prolonged administration. All underlying work is in rodents at doses well above human supplement exposure.

Magnitude: Three of sixteen studies reported suppressed spermatogenesis or hormone levels at high dose or with prolonged dosing; because every study was in rodents, the literature reports no human outcome figure.

Thyroid Disturbance

A published case describes a 36-year-old woman who developed hyperthyroidism (overactive thyroid) while taking 8 g/day of celery extract powder for weight loss; assay of the extract found no thyroid-stimulating substance. Reference sources caution that celery seed may blunt levothyroxine (thyroid hormone replacement) absorption.

Magnitude: Not quantified in available studies. No controlled trial has measured thyroid outcomes with celery seed extract, and the entire signal rests on one case report at a dose roughly six times typical supplement use.

Diuresis and Urinary Frequency

The pharmacological literature consistently describes celery seed as a diuretic, which aids the blood pressure effect but also means more frequent urination and possible electrolyte shifts. Reference sources contraindicate it in active kidney inflammation. The only formal safety evaluation found electrolytes and blood counts unchanged and kidney markers improved.

Magnitude: Increased urine output is described consistently but no trial has measured urine volume; in the one controlled safety evaluation, serum electrolytes were unchanged while blood urea nitrogen fell 3.43 mg/dL and creatinine 0.075 mg/dL.

Speculative 🟨

Bleeding Risk with Anticoagulants

Drug reference sources classify celery root as potentially slowing blood clotting. No case series or trial supports this for the seed extract; the concern is extrapolated from the plant’s coumarin chemistry.

Uterine Stimulation and Pregnancy Loss

Herbal reference sources rate celery seed oil as likely unsafe during pregnancy, based on traditional use to bring on menstruation and reports of herbal infusions used to induce abortion. No controlled data exist.

Mania in Psychiatrically Susceptible Users

A single case report describes mania after celery root extract in a patient taking venlafaxine and St John’s wort, plausibly via slowed drug breakdown. One report cannot establish causation.

Risk-Modifying Factors

  • Pollen sensitization: Birch and mugwort pollen allergy is the dominant risk multiplier. Mugwort-sensitized people carry Api g 7 antibodies that predict severe rather than oral reactions, and the seed is a more concentrated trigger than the vegetable.

  • Baseline blood pressure and medication load: Someone at 118/74 mmHg on two antihypertensives has far more to lose from an additional 9 mmHg than an untreated person at 150/95 mmHg. Measured baseline determines whether the effect helps or harms.

  • Thyroid status and levothyroxine use: Existing thyroid disease or thyroid hormone replacement raises the stakes of both the hyperthyroidism case signal and the reported absorption interference with levothyroxine.

  • Genetic variation in liver enzymes: Poor-metabolizer variants of CYP3A4 or CYP1A2 would raise 3nB exposure, and celery constituents inhibit CYP1A2, which can raise levels of drugs cleared by it. No pharmacogenetic data exist for this extract.

  • Sex and reproductive plans: The fertility inhibition signal is exclusively male and rodent-derived; men actively trying to conceive have a reason for caution that women do not, while pregnancy is a contraindication for women.

  • Age and postural stability: Older adults have stiffer arteries and blunted blood-pressure reflexes, so the same blood pressure drop more often produces dizziness or falls. No trial has enrolled participants over roughly 70 years.

  • Pre-existing bleeding, kidney, or gout-treatment conditions: Bleeding disorders, anticoagulant therapy, and active gout treatment each change the risk calculation, since additive urate-lowering or clotting effects are plausible but unquantified. Active kidney inflammation is a standing contraindication.

Key Interactions & Contraindications

  • Antihypertensive drugs (amlodipine, lisinopril, losartan, hydrochlorothiazide): Caution; additive blood pressure lowering with risk of symptomatic hypotension. Trials added 1.34 g/day on top of standard therapy and still produced 8 to 11 mmHg falls. Home monitoring with physician-supervised dose adjustment is the standard safeguard.

  • Lithium: Caution to absolute avoidance without monitoring; celery’s diuretic action reduces lithium clearance and can push levels into the toxic range. Serum lithium is typically rechecked within one to two weeks of starting or stopping.

  • Levothyroxine: Caution; celery seed is reported to reduce levothyroxine effect, risking under-replacement. Protocols separate the doses by at least four hours and recheck thyroid-stimulating hormone (the pituitary signal used to titrate the dose) after six to eight weeks.

  • Anticoagulants and antiplatelet drugs (warfarin, apixaban, clopidogrel, aspirin): Caution; possible additive slowing of clotting with increased bruising or bleeding. For warfarin users, the clotting time ratio (international normalized ratio) is rechecked within two weeks of starting.

  • CYP1A2 substrates (theophylline, tizanidine, clozapine, caffeine): Caution; celery constituents inhibit this liver enzyme and can raise substrate levels. Consequences range from jitteriness with caffeine to sedation with tizanidine; reduced caffeine intake or spaced dosing is the usual mitigation.

  • Venlafaxine and other serotonergic agents (drugs that raise serotonin, a mood-regulating brain chemical): Caution; slowed breakdown may amplify effects, and a case of mania was reported with celery root extract plus venlafaxine and St John’s wort. Agitation, insomnia, or elevated mood are the warning signs.

  • Photosensitizing drugs (doxycycline, amiodarone, psoralen light therapy): Caution; additive skin phototoxicity with blistering sunburn. Celery products are contraindicated during light therapy combining psoralen drugs with ultraviolet A.

  • Uric-acid-lowering drugs (allopurinol, febuxostat): Monitor; celery flavonoids inhibit the same enzyme, so combined use may over-lower urate. Serum uric acid is rechecked after eight to twelve weeks rather than additivity being assumed harmless.

  • Blood-pressure-lowering supplements (beetroot nitrate, garlic extract, magnesium, omega-3, hibiscus): Caution; stacking several vasodilating or diuretic supplements compounds hypotension risk. Sequential introduction with a two-week gap and home readings between additions limits that stacking.

  • Diuretic herbs and caffeine: Monitor; additive fluid loss can cause dehydration, cramps, or dizziness, particularly with heat or endurance exercise. Higher fluid intake, rather than combined aggressive diuretics, is the usual countermeasure.

Populations who should avoid Celery Seed Extract:

  • Anyone with known celery, mugwort, birch, or Apiaceae-family allergy (carrot, parsley, fennel, anise, caraway, coriander), including oral allergy syndrome (mouth and throat itching after raw plant foods)
  • Pregnant women at any stage, and women planning pregnancy within the next cycle, given the uterine-stimulant classification of celery seed oil
  • Breastfeeding women, on the basis of absent safety data
  • People with a bleeding disorder or on therapeutic anticoagulation without physician supervision
  • People with active kidney inflammation (nephritis) or an estimated glomerular filtration rate below 60 mL/min/1.73 m²
  • People with untreated or unstable thyroid disease (thyroid-stimulating hormone outside 0.4 to 4.0 mIU/L)
  • People with symptomatic blood pressure drops on standing (orthostatic hypotension) or a systolic pressure below 110 mmHg
  • Anyone within two weeks of scheduled surgery
  • People undergoing light therapy with psoralen drugs plus ultraviolet A

Risk Mitigation Strategies

  • Allergy screening before first dose: Celery allergen component testing, including Api g 7, before a first dose is the anaphylaxis safeguard for anyone with birch or mugwort pollen allergy, oral itching from raw carrot, or prior spice reactions.

  • First-dose observation: A first capsule taken at home with another adult present, and no exercise for four hours afterwards, addresses exercise as a documented cofactor for celery-triggered anaphylaxis.

  • Low starting dose with slow titration: Protocols start at 75 to 150 mg once daily for two weeks before moving toward 1,000 to 1,500 mg, limiting the abrupt blood pressure drop that causes dizziness and falls.

  • Home blood pressure logging: Seated and standing pressure logged each morning for the first four weeks is the standard check. A drop below 110/70 mmHg or a 20 mmHg postural fall signals excessive additive hypotension and warrants dose reduction.

  • Medication timing separation: Celery seed extract separated from levothyroxine by at least four hours prevents reduced thyroid hormone absorption; it is likewise not started on the same schedule as a new antihypertensive.

  • Lithium and warfarin level checks: For anyone on lithium or warfarin, a serum lithium level or clotting time ratio within ten to fourteen days of starting covers the two interactions with serious consequences, diuresis and clotting interference.

  • Sun exposure discipline: Sunscreen, covered clothing during the first month, and complete avoidance of tanning beds mitigate the blistering phototoxic reactions reported when celery intake coincides with intense ultraviolet exposure.

  • Planned discontinuation before surgery: Stopping at least fourteen days before any scheduled procedure removes the additive bleeding and hypotension risk during anaesthesia.

  • Periodic thyroid and urate checks: Rechecking thyroid-stimulating hormone and serum uric acid at three months catches the hyperthyroidism signal and any over-correction of urate in people also taking allopurinol.

Therapeutic Protocol

  • Standard supplement protocol: Most integrative practitioners use 150 mg to 1,500 mg daily of a seed extract standardized to 3nB, matching the 1.34 g/day used in the Iranian hypertension trials and the 1,000 mg threshold favoured by the pooled analysis.

  • High-potency standardized approach: The route popularized by naturopathic physician Michael Murray and promoted by Life Extension uses 75 to 150 mg twice daily of an extract standardized to 85 percent 3nB, delivering similar 3nB with far fewer milligrams of material.

  • Low-dose whole-seed approach: The University of Guadalajara group used 150 mg/day of ground celery seed for 12 weeks and still moved blood pressure, triglycerides, and uric acid, suggesting the high-milligram route is not the only option.

  • Split dosing: Divided dosing is standard and mechanistically sensible. Trials gave four capsules across the day; 3nB is heavily oxidized on first pass with most of a dose excreted within a day, so once-daily dosing wastes coverage.

  • Half-life: Human metabolism work found 3nB extensively converted to 23 metabolites with about 82 percent urinary recovery, consistent with an elimination half-life of only a few hours — the practical argument for two to four daily doses.

  • Best time of day: Dosing is with food, morning and early evening. Food improves absorption of the oily phthalides, and a late dose is avoided because the diuretic action increases night-time urination.

  • Genetic considerations: No pharmacogenetic testing is validated here. In principle CYP3A4, CYP2E1, and CYP1A2 variants alter 3nB exposure, and APOE4 or MTHFR status — genes affecting fat transport and folate processing — have no established bearing on dosing.

  • Sex-based differences: No trial has compared dosing between sexes. The sexual-function trial used 1,500 mg/day in women, the hypertension trials mixed sexes at 1.34 g/day; men planning conception may prefer the lower end given the rodent fertility signal.

  • Age-related considerations: Adults over 70 are unstudied. Given stiffer arteries and higher fall risk, starting at 75 to 150 mg daily and titrating over six weeks rather than two is the prudent adaptation at that end of the range.

  • Baseline biomarkers: Response tracks starting values. Blood pressure above 140/90 mmHg, triglycerides above 150 mg/dL, or uric acid above 6 mg/dL identify the people in whom trials found effects; near-optimal baselines predict little change.

  • Pre-existing conditions: Hypertension and metabolic syndrome defined every positive trial. Type 2 diabetes without hypertension is a poor indication, since a dedicated celery-powder trial in that group showed no cardiometabolic benefit.

Discontinuation & Cycling

  • Duration framing: Celery seed extract is a maintenance intervention, not a course. Every trial ran four to twelve weeks and effects reversed on withdrawal in crossover designs, so benefits persist only while it is taken.

  • Withdrawal effects: None documented. Crossover trials with four-week washout periods reported no rebound in blood pressure, mood, or laboratory values, and no discontinuation syndrome has been described in any human study.

  • Tapering: No taper is pharmacologically required given the short residence time. The practical exception is someone whose antihypertensive drugs were reduced while taking it, who needs medication rechecked before stopping.

  • Cycling for efficacy: No evidence supports cycling. Tolerance has never been demonstrated, and the longest trials showed effects maintained at twelve weeks without dose escalation.

  • Cycling for safety: A pragmatic argument exists for periodic breaks. Long-term human safety beyond twelve weeks is untested, so some practitioners use eight to twelve weeks on with two to four weeks off, reassessing biomarkers each cycle.

  • Planned interruptions: Use is interrupted fourteen days before surgery, during psoralen light therapy, and during any pregnancy attempt in women, resuming only once the temporary contraindication has passed.

Sourcing and Quality

  • Standardization is the deciding variable: Products range from whole ground seed to extracts standardized to 85 percent 3nB. Only the 3nB content is comparable across brands, so labels stating milligrams of extract without a 3nB percentage cannot be dose-matched to the trials.

  • Third-party testing: Products carrying NSF International, USP, or Informed Choice certification (independent laboratory quality seals), or a published certificate of analysis, are the verifiable options. Celery seed extract has never been covered by ConsumerLab’s independent testing, so no category-wide label-accuracy data exists.

  • Microbial contamination: Whole celery seed is a spice-category product with documented salmonella recalls, including a 2011 recall of an organic whole celery seed product. Extracts with stated microbiological testing carry less of this risk than unprocessed ground seed.

  • Allergen cross-contact: Facilities processing celery seed frequently also handle other Apiaceae spices such as coriander, fennel, and caraway. An allergen control statement from the manufacturer is the relevant safeguard for anyone with spice allergies.

  • Extraction solvent: The best-characterized preparations are alcoholic extracts of northern Indian seed; supercritical carbon dioxide oils concentrate different phthalide ratios. Preparation types are not interchangeable, so evidence generated with one does not transfer to another.

  • Reputable suppliers: Natural Factors, Swanson, and Life Extension market the most widely used standardized 3nB products. Life Extension both publishes on the ingredient and sells it, so its editorial material carries a direct commercial interest.

  • Heavy metals and pesticides: Seeds concentrate soil contaminants, and celery is routinely on high-pesticide-residue lists. Batch testing against heavy metal and pesticide limits is the relevant documentation, particularly for products of unspecified geographic origin.

Practical Considerations

  • Time to effect: Blood pressure changes appeared by three weeks and were established by four to six weeks in trials. Triglyceride and uric acid changes were measured at four to twelve weeks, so a month is the earliest readable point.

  • Common pitfall — dose mismatch: Buying a 500 mg whole-seed capsule and expecting the effect seen with 1.34 g/day of standardized extract is the single most frequent error, because 3nB content differs by an order of magnitude between formats.

  • Common pitfall — ignoring pollen allergy: Many people with mild seasonal birch or mugwort allergy do not connect it to celery, yet that cross-reactivity is precisely what predicts severe reactions to concentrated seed preparations.

  • Common pitfall — stacking silently: Adding celery seed extract to an existing regimen of beetroot, garlic, and magnesium without home monitoring produces cumulative pressure drops that get misattributed to fatigue or dehydration.

  • Regulatory status: In the United States it is a dietary supplement, so no pre-market efficacy or purity review applies; celery is generally recognized as safe as a food. In the European Union it is a mandatory declared allergen.

  • Structural funding bias: Generic antihypertensives cost pennies daily and are reimbursed; supplements are not. Neither insurers nor national health systems have any incentive to fund head-to-head trials, which is one reason the evidence base stays small and industry-funded.

  • Cost and accessibility: Neither expensive nor hard to obtain — standardized products run roughly 15 to 40 US dollars monthly and are sold without prescription in most markets, so cost is not a meaningful barrier.

Interaction with Foundational Habits

  • Sleep: Indirect and mildly negative if mistimed. The diuretic action increases night-time urination when a dose is taken late, fragmenting sleep. Final doses fall before 6 pm. The anxiety-score improvements seen in hypertensive patients included sleep items, so daytime dosing may net out positive.

  • Nutrition: Direct and potentiating. The active phthalides are fat-soluble, so taking capsules with a meal containing fat improves absorption. Celery seed adds to total dietary Apiaceae exposure, which matters for allergy risk; a diet already high in celery, parsley, and fennel raises cumulative allergen and furocoumarin load.

  • Exercise: Indirect, with one specific caution. Exercise is a documented cofactor that converts tolerated celery exposure into anaphylaxis in susceptible people, so dosing within four hours of hard training is avoided when starting. Combined diuresis and sweating also raises dehydration risk in endurance sessions, making fluid and electrolyte intake matter more.

  • Stress management: Indirect and probably favourable. The crossover trial found reductions in anxiety and depression scores alongside blood pressure falls, with improvement in nervousness, restlessness, and fatigue items. No cortisol or stress-hormone measurement exists, so the mechanism is unknown and may simply reflect better blood pressure control.

Monitoring Protocol & Defining Success

A baseline before starting consists of one week of twice-daily home blood pressure readings taken seated after five minutes of rest, plus a fasting blood draw covering the lipid panel, glucose, uric acid, kidney function, liver enzymes, and thyroid-stimulating hormone. Component-resolved allergy testing is added for anyone with pollen or spice allergy. These baselines matter more than usual here, because every documented benefit is proportional to how abnormal the starting value is, and because the two most serious concerns — excessive blood pressure lowering and thyroid disturbance — are only detectable against a known starting point.

For ongoing monitoring, home blood pressure readings are repeated daily for the first four weeks, then weekly. The full blood panel is repeated at 12 weeks, then every six to twelve months while use continues.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
Systolic / diastolic blood pressure 110–125 / 70–80 mmHg Primary efficacy and primary safety endpoint Seated after 5 min rest; a standing reading catches postural drops. Conventional treatment targets accept up to 140/90 mmHg
Serum uric acid 3.5–5.5 mg/dL Tracks the xanthine oxidase effect Fasting; no alcohol 48 h before. Conventional upper limit is 7.0 mg/dL for men, higher than the functional target
Triglycerides < 80 mg/dL The lipid fraction that responds most consistently 12 h fast; paired with fasting glucose. Conventional cut-off is 150 mg/dL
LDL cholesterol < 100 mg/dL, lower with risk factors Detects whether the inconsistent cholesterol signal applies individually LDL = low-density lipoprotein, the plaque-forming fraction. Best paired with apolipoprotein B
Fasting glucose 75–86 mg/dL Tracks the modest glycaemic effect 12 h fast, morning draw. Conventional normal extends to 99 mg/dL
Thyroid-stimulating hormone 0.5–2.5 mIU/L Screens for the reported hyperthyroidism signal TSH = the pituitary hormone that regulates the thyroid. Morning draw; conventional range extends to 4.0–4.5 mIU/L
Estimated glomerular filtration rate > 90 mL/min/1.73 m² Confirms diuresis is not straining the kidneys eGFR = a calculated measure of kidney filtering capacity. Pair with blood urea nitrogen and creatinine
Sodium and potassium 136–142 and 4.0–4.5 mmol/L Detects electrolyte shift from the diuretic action No shift was seen in the one controlled safety trial; still worth checking when combined with other diuretics
ALT and AST 10–26 U/L Routine safety for any concentrated botanical ALT and AST = liver enzymes that leak into blood when liver cells are stressed. Fasting preferred

Qualitative markers worth tracking alongside the laboratory values:

  • Light-headedness on standing, the earliest sign of excessive blood pressure lowering
  • Night-time urination frequency, which indicates dose timing needs adjusting
  • Any oral itching, lip tingling, or throat tightness after a dose, which requires immediate discontinuation
  • Joint stiffness and morning pain, if joint symptoms are the reason for use
  • Energy, sleep quality, and general anxiety level, the domains where symptom scores improved in trials
  • Skin reaction to sun exposure, particularly in the first month

Emerging Research

  • Celery seed for high uric acid: A three-arm, randomized, double-blind trial of a celery-seed formula in 180 adults with high uric acid (NCT06084585), with 12-week serum uric acid as the primary endpoint. It is sponsored by Amway, which sells the product, and no results have been posted.

  • Metabolic syndrome trial now reported: The Phase 2 trial of 150 mg/day celery seed in 28 adults with metabolic syndrome (NCT06061926) has published results: blood pressure, triglycerides, and uric acid fell, while insulin sensitivity did not change. It remains the only independent low-dose trial.

  • Combination joint formula: A Phase 3 trial of a celery seed, Boswellia, and Phellodendron combination in 110 people with knee osteoarthritis (NCT00577330) has never reported results and its registry status is unknown, leaving the joint claim without a completed single-ingredient test.

  • Evidence that could weaken the case: The celery-powder trial in type 2 diabetes found no cardiometabolic improvement, and the pooled analysis showed no cholesterol effect. A larger, adequately powered, non-Iranian hypertension trial could shrink the reported effect substantially.

  • Allergy diagnostics as a research priority: Ballmer-Weber et al., 2024 call for routine Api g 7 testing, since about a third of celery-allergic patients are missed by extract-based tests. Wider adoption would clarify how much of the population must avoid concentrated seed products.

  • Unresolved dose-response question: Trials cluster at 150 mg/day and 1.34 g/day with nothing between, and no study has compared standardized 3nB percentages head to head. Establishing the minimum effective 3nB dose is the single most useful open question.

Conclusion

Celery seed extract is a concentrated preparation of a common kitchen spice, standardized to an oily aroma compound that relaxes blood vessels much as some blood pressure medicines do, alongside plant pigments that slow the body’s production of uric acid. The most consistent finding is a meaningful fall in blood pressure in people whose pressure is already high, supported by pooled analysis of randomized trials and by placebo-controlled trials of the extract itself. Smaller and less certain signals point to lower blood fats, slightly lower fasting blood sugar, lower uric acid, better mood scores, and improved sexual function in women.

The evidence base is genuinely small. Trials involve dozens rather than thousands of people, run for weeks rather than years, cluster in a few research centres, and measure laboratory values rather than heart attacks or lifespan. A substantial share of the supporting work comes from parties who sell the product — an extract developer, a supplement manufacturer’s research institute, and a magazine publisher that markets the ingredient — and that commercial interest shapes which questions get asked.

Against this sits one serious hazard that has nothing to do with dose: celery is a major allergen, and mugwort or birch pollen sensitivity strongly predicts severe reactions to concentrated seed preparations. The same blood pressure effect that defines the benefit also defines the main risk for anyone already well controlled on medication. Uncertainty here is real and unresolved in both directions.

Top - Benefits - Risks - Protocol